Clinical Trials Directory

Trials / Unknown

UnknownNCT00476489

Does Topical Steroid Treatment Impair the Adrenal Function?

Low Dose (1mcg) ACTH Stimulation Test for Assessment of the Hypothalamo-Pituitary- Adrenal Axis in Patients Treated With Topical Corticosteroids

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if topical steroids treatment for different skin diseases suppress the adrenal cortisol production.

Detailed description

Adrenocortical suppression is a potential complication of systemic corticosteroid treatement but also of non systemic therapy like topical therapy. The normalcy of hypothalamic-pituitary-adrenal axis ( HPA axis) of patients with chronic skin diseases like atopic dermatitis, pemphigus or psoriasis which are treated with topical steroids, will be assessed with the low dose (1mcg) adrenocortocotropin ( ACTH) stimulation test. During this test serum cortisol levels are measured before, 30 and 60 mn after intravenous administration of 1mcg of ACTH (synacthen).The results will be compared with age and sex matched subjects with normal HPA axis as assessed by low dose ACTH stimulation test.

Conditions

Timeline

Start date
2007-05-01
First posted
2007-05-22
Last updated
2007-05-22

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00476489. Inclusion in this directory is not an endorsement.

Does Topical Steroid Treatment Impair the Adrenal Function? (NCT00476489) · Clinical Trials Directory